FDLI Committees

The 2016 committee nomination window has now closed. Nominations will reopen Winter 2016.  We encourage you to explore other opportunities to become engaged with FDLI, including volunteering to serve as a speaker

New, standing, and outgoing committee members will gather at “committee day,” held the day before FDLI’s Annual Conference (May 4) in Washington, DC.

Academic Programs Committee 
Audit Committee 
Austern Writing Awards Committee
Board of Directors 
Drugs and Biologics Committee 
Editorial Advisory Board (Journal) 
Editorial Advisory Board (Policy Forum) 
Editorial Advisory Board (Update) 
Executive Committee  
Finance Committee 
Food and Dietary Supplements Committee
Global Committee
Medical Devices Committee 
Tobacco Committee 


Academic Program Committee

The Academic Programs Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI's mission, relating to programs and publications of interest to the academic legal community. The Committee discusses various programs, publications, pricing, dissemination vehicles, etc. that best facilitate expanding FDLI's educational mission.

  • Marie Boyd (Vice-Chair) University of South Carolina
  • Jess Amchin (Committee Member) Drexel University
  • Katlin McKelvie Backfield (Committee Member) FDA - OC
  • Harvey Alan Berman (Committee Member) State University of NY at Buffalo
  • Laurie J. Beyranevand (Committee Member) Vermont Law School
  • Bianca Buechner (Committee Member) IU Center for Bioethics
  • Sarah diFrancesca (Committee Member) Cooley LLP
  • Jean Frydman (Committee Member) Fox Rothschild LLP
  • Victoria W. Girard (Committee Member) Georgetown University
  • Mary Hendrickson (Committee Member) Sole Practitioner
  • Joseph A. Page (Committee Member) Georgetown University
  • Sean Sweeney (Committee Member) University of Maine
  • Stuart TenHoor (Committee Member) Stuart TenHoor Legal Search
  • Ralph S. Tyler (Committee Member) Venable LLP
  • Seth B Whitelaw (Committee Member) Life Science Compliance
Back to Top

Audit Committee

  • Steven H. Armstrong (Chair) Campbell Soup Company
  • Karen M. Becker (Committee Member) Precision for Medicine
  • Jennifer L. Bragg (Committee Member) Skadden, Arps, Slate, Meagher & Flom LLP
Back to Top

Austern Writing Awards Committee

The H. Thomas Austern Writing Awards Committee assists FDLI staff in determining the award recipient(s) for the best student papers submitted for publication. Members of the Committee (with subcommittees for long and short papers) develop publicity for and promote the competition, and subsequently review all submitted student manuscripts, determining which are most appropriate for awards and/or publication.

  • Deborah C. Attwood (Committee Member) Steptoe & Johnson LLP
  • Nigel Barrella (Committee Member) Law Office of Nigel Barrella
  • Albert F. Cacozza (Committee Member) Ropes & Gray LLP
  • Igor Gorlach (Committee Member) King & Spalding LLP
  • Natasha V. Leskovsek (Committee Member) Cooley LLP
  • Patrick O'Leary (Committee Member) Sidley Austin LLP
  • Caitlyn Ozier (Committee Member) King & Spalding LLP
  • Gail L. Pilgrim (Committee Member) Temple University
  • Matthew Poliner (Committee Member) Venable LLP
  • Margaret F. Riley (Committee Member) University of Virginia
  • Amy Rinaldo (Committee Member) Oakland Law Group, PLLC
  • Celeste Wheeler (Committee Member) Kleinfeld, Kaplan & Becker, LLP
  • Devon Winkles (Committee Member) Kelley Drye & Warren LLP
Back to Top

Board of Directors

  • Allison M. Zieve JD (Chair) Public Citizen
  • Jeffrey N. Gibbs (Vice-Chair) Hyman, Phelps & McNamara, PC
  • Sheila M. Hemeon-Heyer (Immediate Past Chair) Heyer Regulatory Solutions LLC
  • Frederick R. Ball (Treasurer) Duane Morris LLP
  • Joy J. Liu (Secretary and General Counsel) Vertex Pharmaceuticals, Inc.
  • Steven H. Armstrong (Committee Member) Campbell Soup Company
  • Jennifer L. Bragg (Committee Member) Skadden, Arps, Slate, Meagher & Flom LLP
  • Stacy L. Ehrlich (Committee Member) Kleinfeld, Kaplan & Becker, LLP
  • Lewis A. Grossman PhD, JD (Committee Member) American University
  • Freddy A. Jimenez (Committee Member) Celldex Therapeutics, Inc.
  • Scott M. Melville (Committee Member) Consumer Healthcare Products Association (CHPA)
  • Francis B. Palumbo PhD (Committee Member) University of Maryland School of Pharmacy
  • Robert A. Rhoades (Committee Member) Quintiles Transnational Corporation
  • Carmen Shepard (Committee Member) Mylan Pharmaceuticals, Inc.
  • Peter E. Tamborski (Committee Member) SugarCreek Packing Company
  • Amy Comstock Rick (President & CEO) FDLI
Back to Top

Drugs and Biologics Committee

The Drugs and Biologics Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI's mission, relating to programs and publications of interest to the drugs and biologics industries. The Committee advises staff on the appropriateness of conferences and publications relating to pharmaceuticals and biologics by reviewing and commenting on proposals.

  • Ilisa B.G. Bernstein PharmD.,JD (Co-Chair) FDA - CDER
  • Cathy L. Burgess (Co-Chair) Alston & Bird LLP
  • Carolyn Alenci (Committee Member) Duane Morris LLP
  • Clay Alspach (Committee Member) Leavitt Partners
  • Ilisa B.G. Bernstein PharmD.,JD (Committee Member) FDA - CDER
  • Cathy L. Burgess (Committee Member) Alston & Bird LLP
  • Rebecca Burnett (Committee Member) Framework Solutions
  • Krista Hessler Carver (Committee Member) Covington & Burling LLP
  • David V. Ceryak (Committee Member) Eli Lilly and Company
  • Debra Dunne (Committee Member) Shook, Hardy & Bacon LLP
  • Maxine K. Fritz (Committee Member) NSF Health Sciences
  • William A. Garvin (Committee Member) Buchanan Ingersoll & Rooney PC
  • Carolyn Herrmann (Committee Member) Consumer Healthcare Products Association (CHPA)
  • Matthew Hill (Committee Member) Novo Nordisk Inc.
  • Lori F. Hirsch (Committee Member) Merck & Co., Inc.
  • Jennifer Spokes Johansson (Committee Member) Putney Inc.
  • Elizabeth R. Jungman (Committee Member) The Pew Charitable Trusts
  • Aaron S. Kesselheim MD, JD (Committee Member) Harvard Medical School
  • Daniel A. Kracov (Committee Member) Arnold & Porter LLP
  • Areta L. Kupchyk (Committee Member) Foley Hoag LLP
  • Erika F. Lietzan (Committee Member) University of Missouri-Columbia School of Law
  • Brian J. Malkin (Committee Member) McGuireWoods LLP
  • Christina M. Markus (Committee Member) King & Spalding LLP
  • Rikin S. Mehta (Committee Member) Pfizer, Inc.
  • Adora Ndu (Committee Member) FDA - CDER
  • George A. O'Brien (Committee Member) Hogan Lovells LLP
  • Jeffrey Peters (Committee Member) MacroGenics Inc.
  • Kai Peters (Committee Member) Gordon & Rees LLP
  • Christopher Pruitt (Committee Member) FDA - OC
  • Lee Rosebush (Committee Member) Baker & Hostetler
  • Sarah Spurgeon (Committee Member) Amgen Inc.
  • Alicia Subasinghe (Committee Member) PhRMA
  • Alexander J. Varond (Committee Member) Hyman, Phelps & McNamara, PC
  • Mason Weeda (Committee Member) Olsson Frank Weeda Terman Matz PC
  • Lorna C. Wilson (Committee Member) GlaxoSmithKline
Back to Top

Journal Editorial Advisory Board

The Journal Editorial Advisory Board promotes the educational, scholarly, and other purposes of the Food and Drug Law Journal. Members of the Board serve as peer reviewers for papers submitted for publication and recommend topics for "special / symposia" issues.

  • Anthony Anscombe (Committee Member) Sedgwick LLP
  • Barbara A. Binzak Blumenfeld PhD, JD (Committee Member) Buchanan Ingersoll & Rooney PC
  • Kellie B. Combs (Committee Member) Ropes & Gray LLP
  • Nathan G. Cortez (Committee Member) Southern Methodist University
  • Brian A. Dahl (Committee Member) Dahl Compliance Consulting LLC
  • Sandra DePaulis (Committee Member) FDA - CVM
  • Ian Fearon (Committee Member) British American Tobacco
  • James M. Flaherty Jr. (Committee Member) Fresenius Medical Care
  • Robert C. Giddings (Committee Member) Hutchison PLLC
  • Abraham Gitterman (Committee Member) Arnold & Porter LLP
  • Kimberly J. Gold (Committee Member) Norton Rose Fulbright LLP
  • Peter Barton Hutt (Committee Member) Covington & Burling LLP
  • John Johnson (Committee Member) FDAImports.com, LLC/ Benjamin L. England & Associates LLC
  • Alan C. Katz (Committee Member) toXcel, LLC
  • Sara Koblitz (Committee Member) Fish & Richardson P.C.
  • Laurie Lenkel (Committee Member) FDA - OC
  • Valerie Madamba (Committee Member) Sole Practitioner
  • Alan G. Minsk (Committee Member) Arnall Golden Gregory LLP
  • Nicole Negowetti (Committee Member) The Good Food Institute
  • James T. O'Reilly (Committee Member) University of Cincinnati
  • Joseph A. Page (Committee Member) Georgetown University
  • Sandra Retzky (Committee Member) FDA - CTP
  • Jessica Ringel (Committee Member) King & Spalding LLP
  • Joan R. Rothenberg (Committee Member) FDA - CFSAN
  • Jodi Schipper (Committee Member) FDA - CDER
  • Christopher Gail Van Gundy (Committee Member) Keller and Heckman LLP
  • James William Woodlee (Committee Member) Kleinfeld, Kaplan & Becker, LLP
  • Emily Wright (Committee Member) Pfizer, Inc.
  • Kimberly F. Yocum (Committee Member) Heartland
  • Lowell Zeta (Committee Member) Hogan Lovells LLP
  • Patricia Zettler (Committee Member) Georgia State University
Back to Top

Policy Forum Editorial Board

  • Sarah Blankstein (Committee Member) Ropes & Gray LLP
  • Lisa E. Davis (Committee Member) Quarles & Brady LLP
  • Jeffrey K. Francer (Committee Member) PhRMA
  • Ralph F. Ives (Committee Member) AdvaMed
  • Marian J. Lee (Committee Member) Gibson Dunn & Crutcher LLP
  • Susan Lee (Committee Member) Hogan Lovells LLP
  • Jonathan R. McKnight (Committee Member) FDA - CBER
  • Nicholas J. Nowakowski (Committee Member) Oakland Law Group, PLLC
  • Jessica O'Connell (Committee Member) Covington & Burling LLP
  • Flora Chinyere Okereke (Committee Member) British American Tobacco
  • Megan L. Olsen (Committee Member) Kelley Drye & Warren LLP
  • Evangelia Pelonis (Committee Member) Keller and Heckman LLP
  • Christine Perez (Committee Member) American College of Cardiology
  • Matthew Reed (Committee Member) Sedgwick LLP
  • Barry Schaevitz (Committee Member) Fox Rothschild LLP
  • Laura Sim (Committee Member) Amgen Inc.
  • David C. Spangler (Committee Member) Consumer Healthcare Products Association (CHPA)
  • Josephine M. Torrente (Committee Member) Hyman, Phelps & McNamara, PC
  • Daron Watts (Committee Member) Sidley Austin LLP
  • Brian Joseph Wesoloski (Committee Member) Mylan Pharmaceuticals, Inc.
Back to Top

Update Editorial Advisory Board

The Update Editorial Advisory Board promotes the highest levels of professional, educational, and scholarly written commentary on timely issues of interest to professionals in the areas of foods, drugs, biologics, medical devices, other healthcare technologies, and cosmetics in FDLI's magazine The Board serves as a resource for FDLI staff to develop feature theme ideas, acquire articles of interest to readers, and advise on the magazine's quality and success in serving the interests and needs of its readers.

  • Joanne Hawana (Chair) Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • Kari K. Loeser (Vice-Chair) Jazz Pharmaceuticals, Inc.
  • Jacqueline Berman (Committee Member) Morgan, Lewis & Bockius LLP
  • Jacqueline Chan (Committee Member) K&L Gates LLP
  • Bridget C.E. Dooling (Committee Member) Office of Management & Budget
  • Shelly Garg (Committee Member) Sandler, Travis & Rosenberg, P.A.
  • Colleen M. Heisey (Committee Member) Jones Day
  • Alissa Jijon (Committee Member) U.S. Pharmacopeia
  • James R. Johnson (Committee Member) Hogan Lovells LLP
  • Elizabeth F. Lindquist (Committee Member) King & Spalding LLP
  • Gary C. Messplay (Committee Member) King & Spalding LLP
  • Timothy Moore (Committee Member) C.R. Bard, Inc.
  • Nneka C. Onwudiwe (Committee Member) FDA - CDER
  • Krasimira S Pekova (Committee Member) Northeastern University
  • Karen Sie (Committee Member) Norton Rose Fulbright LLP
  • Genevieve M. Spires (Committee Member) Buchanan Ingersoll & Rooney PC
  • Smitha G. Stansbury (Committee Member) King & Spalding LLP
  • James Valentine (Committee Member) Hyman, Phelps & McNamara, PC
  • Andrew Wasson (Committee Member) Frommer Lawrence & Haug LLP
Back to Top

Executive Committee

  • Allison M. Zieve JD (Chair) Public Citizen
  • Jeffrey N. Gibbs (Vice-Chair) Hyman, Phelps & McNamara, PC
  • Frederick R. Ball (Treasurer) Duane Morris LLP
  • Joy J. Liu (Secretary and General Counsel) Vertex Pharmaceuticals, Inc.
  • Amy Comstock Rick (President & CEO) FDLI
Back to Top

Finance Committee

The purpose of the Finance Committee is to ensure the responsible financial operations of FDLI. The Committee provides on-going oversight of the financial operations and investment policies of FDLI to ensure sound financial management. The Committee also advises the Board on the direction and control of financial matters. The Committee also ensures that the Board is well informed about the Institute's finances.

  • Frederick R. Ball (Chair) Duane Morris LLP
  • Scott M. Melville (Board Liaison) Consumer Healthcare Products Association (CHPA)
  • Kellie B. Combs (Committee Member) Ropes & Gray LLP
  • David M. Fox (Committee Member) Hogan Lovells LLP
  • Peter Pitts (Committee Member) Center for Medicine in the Public Interest
Back to Top

Food and Dietary Supplements Committee

The Food and Dietary Supplements Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI's mission, relating to programs and publications of interest to the food and dietary supplement industries. The Committee advises staff on the appropriateness of conferences and publications relating to foods and dietary supplements by reviewing and commenting on proposals.

  • Miriam J. Guggenheim (Co-Chair) Covington & Burling LLP
  • Leslie T. Krasny (Co-Chair) Keller and Heckman LLP
  • Rend Al-Mondhiry (Committee Member) Council for Responsible Nutrition
  • Stephanie K. Barnes (Committee Member) Food Marketing Institute
  • Ted Elkin (Committee Member) FDA - CFSAN
  • Jennifer Erickson (Committee Member) FDA - CVM
  • Sandra B. Eskin Esq. (Committee Member) The Pew Charitable Trusts
  • Elizabeth Barr Fawell (Committee Member) Hogan Lovells LLP
  • Ben Firschein (Committee Member) U.S. Pharmacopeia
  • Les Alan Glick (Committee Member) Porter Wright Morris & Arthur LLP
  • James C. Huang (Committee Member) The Coca-Cola Company
  • Patricia Knight (Committee Member) Knight Capitol Consultants
  • Chi-Hua Lu (Committee Member) Abbott Nutrition
  • Diane C. McEnroe (Committee Member) Sidley Austin LLP
  • Meredith Q. Olearchik (Committee Member) Campbell Soup Company
  • Stuart M. Pape (Committee Member) Polsinelli PC
  • Justin J. Prochnow (Committee Member) Greenberg Traurig, LLP
  • Ronald Y. Rothstein (Committee Member) Winston & Strawn LLP
  • Jason W. Sapsin (Committee Member) Faegre Baker Daniels LLP
  • Brooke Schumm III (Committee Member) Daneker, McIntire, Schumm
  • Bruce A. Silverglade (Committee Member) Olsson Frank Weeda Terman Matz PC
  • Suzanne Loonam Trigg (Committee Member) Haynes and Boone LLP
  • Amanda Triner (Committee Member) FDA - CFSAN
  • Andrew R. Varcoe (Committee Member) Biotechnology Innovation Organization
Back to Top

Global Committee

The Global Committee advises FDLI staff on international conferences and domestic meetings with global content as well as publications marketed to an international audience. Its duties and responsibilities include advising staff on ongoing developments in specific countries and helping staff keep current on global legal, regulatory and policy issues. The committee includes one ex-officio member from the following committees and editorial advisory boards: Academic Programs, Food and Dietary Supplements, Medical Devices and Diagnostics, Drugs & Biologics, Update, Food and Drug Law Journal and Food and Drug Policy Forum as well as other at-large members.

  • Robert A. Rhoades (Board Liaison) Quintiles Transnational Corporation
  • Philip S. Brewster (Committee Member) Brewster Law Firm LLC
  • Jill M. Daley (Committee Member) Sole Practitioner
  • Patrick C. Gallagher (Committee Member) Duane Morris LLP
  • Robert Kozak (Committee Member) Bayer Corporation
  • Otto B. Licks (Committee Member) Licks Advogados
  • Dorothy Linvill-Neal (At-Large) Novartis Pharmaceuticals Corporation
  • Christian Lopez-Silva (Committee Member) Baker & McKenzie
  • Jacqueline Mailly (Committee Member) Hogan Lovells LLP
  • Maureen E. McGirr (Committee Member) Merck & Co., Inc.
  • Daniel Moelands (At-Large) Medtronic
  • Jeff Nelligan (Committee Member) FDA - ORA
  • Peter Pitts (Committee Member) Center for Medicine in the Public Interest
  • Teresa Reguly (Committee Member) Torys LLP
  • Sarah Taylor Roller (Committee Member) Kelley Drye & Warren LLP
  • Denise Sturdy (Committee Member) Duke Clinical Research Institute
  • Sara Zborovski (At-Large) Norton Rose Fulbright LLP
Back to Top

Medical Devices Committee

The Medical Devices Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI's mission, relating to programs and publications of interest to the Medical Devices industries. The Committee advises staff on the appropriateness of conferences and publications relating to medical devices by reviewing and commenting on proposals.

  • Paul Gadiock (Co-Chair) FDA - CDRH
  • Vernessa T. Pollard (Co-Chair) McDermott Will & Emery
  • Jeffrey N. Gibbs (Board Liaison) Hyman, Phelps & McNamara, PC
  • Linda D. Bentley (Committee Member) Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • David E. Chadwick PhD (Committee Member) Cook Group Incorporated
  • Michael E. Clark (Committee Member) Duane Morris LLP
  • David K. Elder (Committee Member) Greenleaf Health LLC
  • Sonali P. Gunawardhana (Committee Member) Wiley Rein LLP
  • John Hamilton (Committee Member) Burns & Levinson LLP
  • Sandra C. Kalter (Committee Member) Medtronic
  • Gregory H. Levine (Committee Member) Ropes & Gray LLP
  • Mark C. Levy (Committee Member) Eckert Seamans Cherin & Mellott, LLC
  • Kevin M. Madagan (Committee Member) Reed Smith LLP
  • John R. Manthei (Committee Member) Latham & Watkins LLP
  • Alexandra Marzelli (Committee Member) BD
  • Eileen M. McMahon (Committee Member) Torys LLP
  • Mary Monovoukas (Committee Member) Boston Scientific Corporation Inc.
  • Phoebe Mounts PhD (Committee Member) Morgan, Lewis & Bockius LLP
  • Maura Martin Norden (Committee Member) Greenleaf Health LLC
  • Kelly N. Reeves (Committee Member) King & Spalding LLP
  • Marc J. Scheineson (Committee Member) Alston & Bird LLP
  • Jeffrey K. Shapiro (Committee Member) Hyman, Phelps & McNamara, PC
  • Nancy Singer (Committee Member) Compliance-Alliance, LLC
  • Lynn C. Tyler (Committee Member) Barnes & Thornburg LLP
  • Marta L. Villarraga PhD (Committee Member) Exponent, Inc.
  • Kristi L. Wolff (Committee Member) Kelley Drye & Warren LLP
Back to Top

Tobacco Committee

The Tobacco Committee advises FDLI staff in formulating and implementing policies and strategies relating to programs and publications about law, regulation and policy affecting tobacco products. Duties and Responsibilities include advising staff on the appropriateness of conferences and publications relating to this topic area by suggesting topics and reviewing and commenting on proposals.

  • Stacey Gagosian (Chair) Truth Initiative
  • Stacy L. Ehrlich (Board Liaison) Kleinfeld, Kaplan & Becker, LLP
  • Azim Chowdhury (Committee Member) Keller and Heckman LLP
  • Dean R. Cirotta (Committee Member) EAS Consulting Group, LLC
  • Gal Cohen (Committee Member) Pax Labs, Inc.
  • Stacey Gagosian (Committee Member) Truth Initiative
  • Joseph Graham Gitchell (Committee Member) Pinney Associates, Inc.
  • Jonathan A. Havens (Committee Member) Saul Ewing LLP
  • Bryan M. Haynes (Committee Member) Troutman Sanders LLP
  • Dennis Henigan (Committee Member) Campaign for Tobacco-Free Kids
  • Ondrej Koumal (Committee Member) Philip Morris International
  • Marina A. Murphy (Committee Member) British American Tobacco
  • May D. Nelson (Committee Member) FDA - CTP
  • Mitchell A. Neuhauser (Committee Member) Reynolds American, Inc.
  • James M. Solyst MS (Committee Member) Swedish Match North America
  • Taryn Fritz Walpole (Committee Member) Greenleaf Health LLC
Back to Top